CLIA-waived status approved for drug, flu, strep tests & more

Why This Topic Matters

Changes to CLIA-waived status can affect how laboratory claims are processed and whether payer systems recognize tests appropriately. Staying current with the implementation notices helps practices avoid claim denials and understand when retroactive adjustment may need to be requested.

Article Sections

1. Overview of CLIA-waived status updates

   Introduces the update and explains that new tests were approved for waived status. It also notes the role of implementation dates and carrier edits.

2. First group of approved lab tests

   Summarizes the initial set of waived laboratory tests referenced in the CMS notification and associated effective dates. The section focuses on the administrative update rather than clinical details.

3. Claims handling and retroactive adjustments

   Discusses payer processing considerations for claims tied to the newly waived tests. It addresses the need for carrier attention on claims that may require adjustment.

4. Second group of approved lab tests

   Covers the later CMS transmittal announcing additional waived laboratory tests and their implementation timing. The section continues the administrative overview of the expanded list.